Inclusion Criteria:  Patients aged >18 years using DOAC and undergoing elective ICA or PCI. Provided signed informed consent  Exclusion Criteria:  A potential subject who meets any of the following criteria will be excluded from participation in this study:  Any of the following:  Patients initially presenting with Acute Coronary Syndrome (STEMI, NSTEMI, UA) Patients <18 years old Calculated CLCR <30 mL/min Patients simultaneously participating in another clinical trial  History or condition associated with increased bleeding risk, as listed below:  Major surgical procedure within 30 days before the procedure Known inaccessible radial artery during previous procedure History of GI bleeding in the previous 6 months History of intracranial, intraocular, spinal, or atraumatic intra-articular bleeding Chronic bleeding disorder Known intracranial neoplasm, arteriovenous malformation, or aneurysm Known anemia with last measured haemoglobin value <6 mmol/L [9.67 g/dL] Current pregnancy or breast-feeding Known significant liver disease (e.g., acute clinical hepatitis, chronic active hepatitis, cirrhosis), or ALT >3 x the ULN Participation in another clinical trial